Jane Street’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
Other funds holding PMVP
BCM
TCM
SCM
EC
ACH
EP
Jane Street's PMVP Position: Q2 2026 in Review
Jane Street reduced its PMV Pharmaceuticals (PMVP) stake by 68% in Q2 2026, selling an estimated $108K and leaving 40,207 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #10900.
Jane Street first reported a position in PMVP in Q3 2020 and has held it in 15 quarters since. The position peaked at $1.12M in Q1 2023. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.
- Jane Street held 40,207 shares of PMV Pharmaceuticals worth $53.9K as of Q2 2026.
- Jane Street sold 83,807 PMV Pharmaceuticals shares in Q2 2026, an estimated $108K.
- PMV Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10900 holding.
- Jane Street first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 15 quarters since.
- Jane Street's PMV Pharmaceuticals position peaked at $1.12M in Q1 2023.
- 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.